These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 6168898)

  • 21. [Type and subtype distribution of influenza virus and genetic evolution of hemagglutinin in Shanghai area in duration of 2004 - 2008].
    Yang JX; Ju LW; Jiang LF; Shi Q; Jiang QW; Zhang YY; Zhou YB; Shen HG; Tan YY
    Zhonghua Yu Fang Yi Xue Za Zhi; 2009 Apr; 43(4):305-8. PubMed ID: 19534952
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dual infections by influenza A/H3N2 and B viruses and by influenza A/H3N2 and A/H1N1 viruses during winter 2007, Corsica Island, France.
    Falchi A; Arena C; Andreoletti L; Jacques J; Leveque N; Blanchon T; Lina B; Turbelin C; Dorléans Y; Flahault A; Amoros JP; Spadoni G; Agostini F; Varesi L
    J Clin Virol; 2008 Feb; 41(2):148-51. PubMed ID: 18069055
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Influenza vaccine 2008-2009.
    Med Lett Drugs Ther; 2008 Oct; 50(1296):77-9. PubMed ID: 18833032
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cross-subtype protection in humans during sequential, overlapping, and/or concurrent epidemics caused by H3N2 and H1N1 influenza viruses.
    Sonoguchi T; Naito H; Hara M; Takeuchi Y; Fukumi H
    J Infect Dis; 1985 Jan; 151(1):81-8. PubMed ID: 3965596
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Using surveillance to evaluate influenza vaccine effectiveness.
    Jackson LA
    J Infect Dis; 2009 Jan; 199(2):155-8. PubMed ID: 19086916
    [No Abstract]   [Full Text] [Related]  

  • 26. Etiology of influenza viruses isolated in Russia from 1998 up to present time.
    Konovalova NI; Litvinova OM; Gudkova TM; Lobova TG; Grigorieva VA; Eropkin MU; Yaglovskaya IB
    Vaccine; 2006 Nov; 24(44-46):6697-700. PubMed ID: 16920234
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reinfection with influenza A (H2N2, H3N2, and H1N1) viruses in soldiers and students in Japan.
    Sonoguchi T; Sakoh M; Kunita N; Satsuta K; Noriki H; Fukumi H
    J Infect Dis; 1986 Jan; 153(1):33-40. PubMed ID: 3941288
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Investigation of exposure to swine influenza viruses in Ontario (Canada) finisher herds in 2004 and 2005.
    Poljak Z; Friendship RM; Carman S; McNab WB; Dewey CE
    Prev Vet Med; 2008 Jan; 83(1):24-40. PubMed ID: 17604859
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Investigation of an outbreak of influenza by A/Vict./3/75 (H3N2) virus strain in Kharakwasla in 1980.
    Bhattacharya SR; Rai J; Suri PN; Krishna K; Shukla RN
    Indian J Pathol Microbiol; 1983 Apr; 26(2):77-80. PubMed ID: 6654448
    [No Abstract]   [Full Text] [Related]  

  • 30. Emergence and phylogenetic relationships of amantadine-resistant human H3N2 influenza A viruses in Germany in the season 2005/2006.
    Schmidtke M; Bauer K; Ludwig N; Wutzler P
    Int J Antimicrob Agents; 2008 Aug; 32(2):192-5. PubMed ID: 18571381
    [No Abstract]   [Full Text] [Related]  

  • 31. Surveillance of resistance to adamantanes among influenza A(H3N2) and A(H1N1) viruses isolated worldwide.
    Deyde VM; Xu X; Bright RA; Shaw M; Smith CB; Zhang Y; Shu Y; Gubareva LV; Cox NJ; Klimov AI
    J Infect Dis; 2007 Jul; 196(2):249-57. PubMed ID: 17570112
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Update: Influenza activity--United States and worldwide, 2006-07 season, and composition of the 2007-08 influenza vaccine.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2007 Aug; 56(31):789-94. PubMed ID: 17687244
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Influenza season 2007/'08 in the Netherlands: antigenic variation, oseltamivir resistance and vaccine composition for the 2008/'09 season].
    Rimmelzwaan GF; de Jong JC; Donker GA; Meijer A; Fouchier RA; Osterhaus AD
    Ned Tijdschr Geneeskd; 2008 Sep; 152(39):2138-44. PubMed ID: 18856032
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Implications of antiviral resistance of influenza viruses.
    Monto AS
    Clin Infect Dis; 2009 Feb; 48(4):397-9. PubMed ID: 19586376
    [No Abstract]   [Full Text] [Related]  

  • 35. Human trials with wild-type H1N1 and recombinant H3N2-H1N1 influenza A viruses of 1977-1978.
    Beare AS; Kendal AP; Cox NJ; Scholtissek C
    Infect Immun; 1980 Jun; 28(3):753-61. PubMed ID: 7399693
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Amantadine-resistant influenza A viruses isolated in South Korea from 2003 to 2009.
    Choi WY; Kim S; Lee N; Kwon M; Yang I; Kim MJ; Cheong SG; Kwon D; Lee JY; Oh HB; Kang C
    Antiviral Res; 2009 Nov; 84(2):199-202. PubMed ID: 19720085
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Community-wide surveillance of influenza after outbreaks due to H3N2 (A/Victoria/75 and A/Texas/77) and H1N1 (A/USSR/77) influenza viruses, Mercer County, New Jersey, 1978.
    Glass RI; Brann EA; Slade JD; Jones WE; Scally MJ; Craven RB; Gregg MG
    J Infect Dis; 1978 Nov; 138(5):703-6. PubMed ID: 712125
    [No Abstract]   [Full Text] [Related]  

  • 38. Ultrastructure and some biological properties of influenza A virus. II. Effect of physico-chemical factors on influenza A virus and its interferonogenic properties.
    Chomik M
    Arch Immunol Ther Exp (Warsz); 1988; 36(4):459-64. PubMed ID: 2471480
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Combined use of interferon inducers and recombinant influenza viruses for protection from the disease].
    Podcherniaeva RIa; Shchipanova MV; Nosik NN; Ershov FI; L'vov DK
    Vopr Virusol; 1984; 29(2):173-5. PubMed ID: 6203227
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Influenza 1989/'90: A-H3N2 virus related to the vaccine virus].
    Sprenger MJ; Diepersloot RJ; Stuiver M; Postema CA; Masurel N
    Ned Tijdschr Geneeskd; 1990 Mar; 134(13):663-4. PubMed ID: 2320171
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.